Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could microneedling make scar treatment less painful and more effective?

NCT ID NCT07718269

Disease control Sponsor: Alexandria University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This trial tests whether applying the drug 5-fluorouracil through microneedling works better than standard injections of the same drug or corticosteroids for treating hypertrophic scars and keloids. About 60 adults with these raised scars will receive one of four treatments. Researchers will measure changes in scar appearance using a standard scale to see which approach is safest and most effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
microneedling with 5-fluorouracil, intralesional 5-fluorouracil, intralesional triamcinolone acetonide, or microneedling with saline
What this could lead to
If microneedling-assisted delivery works better than standard injections, it could offer a less painful, more effective treatment for raised scars.
What could go wrong
This is a small, single-center trial, so results may not apply broadly. Microneedling itself can cause temporary redness or irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

60 people

The number who actually took part.

Started

Jan 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients diagnosed with HTSs or keloids Exclusion Criteria: * pregnant or lactating females, immunocompromised patients

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertrophic scar are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cicatrix, Hypertrophic keloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertrophic scar Keloid scars

Contacts and locations

Locations

  • alexandria University Hospital

    Alexandria, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.